← Back to Search

Decision Aid for Gender Dysphoria

N/A

Waitlist Available

Led By Rachel A. Moses, MD, MPH

Research Sponsored by Dartmouth-Hitchcock Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Assigned female on the original birth certificate

Aged 18 or older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately after using the decision aid (approximately 2-4 weeks from baseline)

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to test a new online tool that provides information to help individuals considering Gender Affirming Surgery make informed decisions. Participants will either receive standard care or use the web-based decision aid and provide

Who is the study for?

This trial is for transgender individuals considering gender-affirming surgeries, specifically metoidioplasty and phalloplasty. Participants should be in the decision-making process regarding these surgeries and willing to provide feedback on a new online decision aid tool.

What is being tested?

The study tests an online tool designed to help with decisions about Metoidioplasty and Phalloplasty Gender Affirming Surgery (MaPGAS). It compares the experiences of those using this tool against those receiving standard care, focusing on user-friendliness and its impact on surgery readiness.

What are the potential side effects?

Since this trial involves an informational decision aid rather than a medical intervention, there are no direct physical side effects. However, participants may experience emotional or psychological responses related to engaging with information about surgical options.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I was assigned female at birth.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within one week following the surgical consultation.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within one week following the surgical consultation.

This trial's timeline: 3 weeks for screening, Varies for treatment, and within one week following the surgical consultation. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Decisional Conflict Scale (DCS) Score Change

Preparation for Decision Making (PrepDM) Scale Score Change

Secondary study objectives

CollaboRATE Score Change Post-Surgical Consultation

System Usability Scale (SUS) Score

Other study objectives

Qualitative Feedback from Cognitive Interviews

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: MaPGAS Decision Aid InterventionExperimental Treatment1 Intervention

Participants in this arm will be provided with access to a novel, web-based decision aid designed for individuals considering MaPGAS. The decision aid includes interactive components, educational materials regarding surgical options, risks, benefits, and patient testimonials. Participants will have unlimited access to the decision aid for four weeks prior to their surgical consultation.

Group II: MaPGAS Usual CareActive Control1 Intervention

Participants in this arm will receive the standard pre-consultation care provided by their healthcare provider, which does not include access to the novel decision aid. Standard care may include informational brochures. This group serves to compare the outcomes of traditional decision-making processes with those who use the decision aid.

0 / 2Eligibility criteria met